In the present studies, the influence of inducible nitric oxide syntha
se (NOS) inhibition with aminoguanidine on renal function and blood pr
essure was examined in rats. Intravenous aminoguanidine infusion (60 m
g . kg(-1) . hr(-1)) for 40 minutes to anesthetized Sprague-Dawley rat
s (n=7) resulted in no significant changes in mean arterial pressure o
r renal cortical blood now, while medullary-blood now was slightly inc
reased. Despite minimal effects on renal blood now, urine now was sign
ificantly decreased from 14.2+/-2.7 to 10.4+/-2.3 mu L . min(-1) . g k
idney wt(-1) during aminoguanidine infusion. To examine the possible e
ffects of inducible NOS on blood pressure, aminoguanidine (10 mg . kg(
-1) . h(-1) IV) was infused chronically into uninephrectomized rats ma
intained on a high salt (4.0% NaCl) diet. Mean arterial pressure signi
ficantly increased from 104+/-2 to 118+/-3 mm Hg after 6 days of amino
guanidine infusion (n=7) and returned to levels not different from tho
se in the control group after 2 days of postcontrol infusion. Calcium-
independent NOS activity in the renal medulla, a tissue that expresses
inducible NOS in normal rats, was significantly decreased by 49% in t
he aminoguanidine-infused group (n=6) compared with that activity in t
he vehicle-infused control animals (n=6). In contrast, calcium-depende
nt NOS activity in the renal medulla was not significantly altered by
aminoguanidine infusion, indicating specificity of aminoguanidine for
inducible NOS in these experiments. In a final group of rats (n=5), or
al L-arginine administration in drinking water (2% wt/vol) increased p
lasma arginine levels from 118+/-5 to 232+/-16 mu mol/L and blocked th
e increase in arterial pressure after 6 days of aminoguanidine infusio
n. The present experiments provide evidence supporting a role for indu
cible NOS in the control of arterial pressure, possibly by renal tubul
ar effects.